A vaccine that could cure diabetes to be tested at MGH against coronavirus

A generic vaccine that's shown promise in reversing type 1 diabetes long-term in trials at Massachusetts General Hospital will soon have a new target: the COVID-19 coronavirus.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

I have results from my clinic… Three of my diabetic patients went into remission after using hyperbaric oxygen therapy (HBOT). Two patients had type 1 diabetes… and another had type 2 diabetes. All three recovered with oxygen therapy. Most mainstream doctors would scoff at the idea… they “know” there’s no cure for diabetes. And to be treated for it with oxygen seems laughable. If you’re a regular reader, you know more about oxygen therapy than 99% of the general public, including most doctors. But the reason diabetes responds so well to oxygen may surprise you… It al...
Source: Al Sears, MD Natural Remedies - Category: Complementary Medicine Authors: Tags: Health Source Type: news
In the absence of an effective drug or vaccine against novel severe acute respiratory syndrome corona virus (SARS-Cov-2) till date, “repurposing approach” of old pharmaceuticals has been applied to combat against 2019-coronavirus disease (COVID-19). Hydroxychloroquine, anti-retrovirals, type-1 angiotesin receptor blockers, statin, vitamin D, melatonin etc are being tried with questionable benefits [1]. While there are intens ive debates regarding safety of different classes of antidiabetics at the advent of COVID-19 [2,3], multiple ongoing studies are evaluating the adjuvant role of various antidiaetics like di...
Source: Primary Care Diabetes - Category: Primary Care Authors: Tags: Letter to the Editor Source Type: research
The risk of death from COVID-19 is three and a half times higher for patients with type 1 diabetes and two times higher for those with type 2 diabetes, compared with people without the condition, new NHS research shows.
Source: GP Online News - Category: Primary Care Tags: Coronavirus Source Type: news
The global concern is currently focused on the novel coronavirus, named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which was isolated in China in January 2020. This virus is responsible for an outbreak of pneumonia, defined as coronavirus disease 2019 (COVID-19), which appeared in Hubei province (China) at the end of 2019 and later spread worldwide [1].
Source: Diabetes Research and Clinical Practice - Category: Endocrinology Authors: Tags: Commentary Source Type: research
NHS ’s first breakdown of underlying health conditions also finds 18% had dementiaCoronavirus – latest updatesSee all our coronavirus coverageOne in four people who havedied in hospital with Covid-19 also had diabetes, the NHS ’s first breakdown of underlying health conditions among the fatalities shows.Of the 22,332 people who died in hospital in England between 31 March and 12 May, 5,873 (26%) suffered from either type 1 or type 2 diabetes, NHS England figures reveal.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak UK news Diabetes Heart disease Dementia NHS Hospitals Health Infectious diseases Medical research Mental health Microbiology Science Society Source Type: news
ConclusionDespite the limited possibility to exercise and the incumbent psychologic stress, glycaemic control improved in patients with T1D who stopped working during the lockdown, suggesting that slowing down routine daily activities can have beneficial effects on T1D management, at least in the short term.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research
There was a lot to unpack from Dexcom's first-quarter earnings call this week, but one of the key takeaways from management comments is that diabetes patients and caregivers are latching onto telemedicine as a way to stay on top of their glucose levels during COVID-19. This isn't surprising, given that we've seen a substantial increase in telemedicine adoption across healthcare during this crisis, but it is especially important for newly diagnosed patients needing continuous glucose monitoring (CGM) technology. "Our extensive virtual resources for patient and clinician training and customer support are proving to be e...
Source: MDDI - Category: Medical Devices Authors: Tags: COVID-19 Digital Health Source Type: news
Endocrinologists and a diabetes charity are warning GPs and the public to be '4T aware' and attentive to symptoms suggestive of new-onset type 1 diabetes during the coronavirus pandemic.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Endocrinologists and a diabetes charity are warning GPs and the public to be'4T aware'and attentive to symptoms suggestive of new-onset type 1 diabetes during the coronavirus pandemic.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Preliminary data from China suggest that people with diabetes and other preexisting conditions are more likely to experience serious complications and death from COVID-19 than people without diabetes and other conditions. But COVID-19 and the coronavirus that causes it are new, and researchers are still investigating how they impact immunity. We also know that if a person has diabetes and gets influenza or another infection, they can experience worse health outcomes. The question is why. High blood sugars can interfere with white blood cells’ ability to fight infection. So there’s a possibility that people with...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Diabetes Health Source Type: blogs
More News: Biotechnology | Coronavirus | COVID-19 | Diabetes | Diabetes Type 1 | Endocrinology | Health Management | Hospitals | Vaccines